HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunohistochemical characterization of non-epithelial cells in spiradenoma.

Abstract
Spiradenoma is unique with respect to the presence of a large number of non-epithelial cells, including S100 protein(+) cells, most of which are presumably Langerhans cells, in the parenchyma as shown in the published work. However, the characterization of these non-epithelial cells to date is insufficient. Immunohistochemistry of CD1a, CD3, CD4, CD8, CD56, CD68, intercellular adhesion molecule-1 (ICAM-1), and HLA-DR, as well as double-immunofluorescence labeling of S100 protein/CD1a and CD1a/CD3, was performed using paraffin-embedded specimens from five cases of spiradenoma retrospectively. Non-epithelial cells evenly distributed throughout the parenchyma of spiradenoma primarily consisted of CD1a(+) Langerhans cells and CD3(+) T cells. ICAM-1 was expressed by epithelial cells and non-epithelial cells in the parenchyma. HLA-DR on the epithelial cells was limited to the focal area. In double-immunofluorescence labeling, approximately one-half of Langerhans cells were spatially related to T cells in the parenchyma, suggesting their functional interaction.
AuthorsKohji Iida, Shinsaku Iwai, Hiroomi Hosaka, Yuki Kitami, Masaki Akiyama, Takao Suzuki, Hirohiko Sueki
JournalThe Journal of dermatology (J Dermatol) Vol. 40 Issue 11 Pg. 896-900 (Nov 2013) ISSN: 1346-8138 [Electronic] England
PMID24580131 (Publication Type: Journal Article)
Copyright© 2013 Japanese Dermatological Association.
Chemical References
  • Antigens, CD1
  • CD1a antigen
Topics
  • Adenoma (immunology, pathology)
  • Adult
  • Aged
  • Antigens, CD1 (analysis)
  • Female
  • Humans
  • Immunohistochemistry
  • Langerhans Cells (chemistry, pathology)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Skin (immunology, pathology)
  • Skin Neoplasms (immunology, pathology)
  • T-Lymphocytes (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: